{"id":9007,"date":"2025-10-23T18:03:01","date_gmt":"2025-10-23T15:03:01","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=9007"},"modified":"2025-10-23T18:03:01","modified_gmt":"2025-10-23T15:03:01","slug":"mri-workup-of-ischemic-heart-disease-insights-and-innovations","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/mri-workup-of-ischemic-heart-disease-insights-and-innovations\/","title":{"rendered":"MRI Workup of Ischemic Heart Disease \u2014 Insights and Innovations"},"content":{"rendered":"<div>MRI Workup of Ischemic Heart Disease \u2014 Insights and Innovations<\/div>\n<div><\/div>\n<div>Source: Medscape (Supported by Bayer)<\/div>\n<div>Date: 21, October 2025<\/div>\n<div><\/div>\n<div>Keynotes:<\/div>\n<div>1. Purpose<\/div>\n<div>Cardiac Magnetic Resonance (CMR) is a specialized, non-invasive test used to assess heart muscle structure, function, perfusion, and scarring.<\/div>\n<div>It complements coronary CT angiography (CCTA), which focuses mainly on coronary artery visualization.<\/div>\n<div><\/div>\n<div>2. Cine Imaging<\/div>\n<div>Cine imaging acts like a moving video of the beating heart, synchronized with the ECG.<\/div>\n<div>It shows ventricular wall motion, contractility, and ejection fraction, allowing detection of ischemic wall motion abnormalities and stunned myocardium.<\/div>\n<div><\/div>\n<div>3. Perfusion Imaging<\/div>\n<div>Perfusion sequences evaluate blood flow to the myocardium at rest and under stress.<\/div>\n<div>They identify ischemic or underperfused regions and guide treatment or revascularization decisions.<\/div>\n<div><\/div>\n<div>4. Late Gadolinium Enhancement (LGE)<\/div>\n<div>LGE detects fibrosis and scarring caused by prior infarction or inflammation.<\/div>\n<div>It distinguishes viable from non-viable myocardium, predicting the likelihood of recovery after PCI or CABG.<\/div>\n<div>LGE imaging is typically performed 10\u201315 minutes after contrast injection.<\/div>\n<div><\/div>\n<div>5. T2 Imaging<\/div>\n<div>T2-weighted sequences reveal myocardial edema, a sign of acute injury or inflammation.<\/div>\n<div><span> \u2022 In acute MI, T2 and LGE follow a coronary distribution (subendocardial or transmural).<\/span><\/div>\n<div><span> \u2022 In myocarditis, edema appears patchy or lateral, often with subepicardial or mid-wall enhancement.<\/span><\/div>\n<div>Combining T2, LGE, and cine data helps distinguish inflammation from ischemic necrosis.<\/div>\n<div><\/div>\n<div>6. MR Angiography (MRA)<\/div>\n<div><\/div>\n<div>CMR can incorporate Magnetic Resonance Angiography (MRA) to visualize major vessels \u2014 such as the aorta, pulmonary arteries, carotid, renal, and limb arteries \u2014 without radiation.<\/div>\n<div>It helps detect aneurysm, dissection, thrombosis, stenosis, or congenital anomalies, providing a radiation-free vascular map.<\/div>\n<div>MRA is ideal for imaging large-vessel anatomy in the chest, neck, abdomen, and extremities, but not for coronary arteries, where CT angiography remains superior.<\/div>\n<div><\/div>\n<div>7. Contrast Use and Kidney Safety in MRA<\/div>\n<div>MRA does not use iodine-based contrast like CT angiography.<\/div>\n<div>Instead, it employs Gadolinium-based contrast agents (GBCA) \u2014 lighter, safer, and rarely nephrotoxic.<\/div>\n<div>They are safe for most patients except those with severe renal failure (eGFR &lt; 30 mL\/min).<\/div>\n<div>In such cases, non-contrast MRA techniques can still be performed effectively.<\/div>\n<div><\/div>\n<div>\u00a0 \u00a0Both MRI and MRA use the same Gadolinium contrast \u2014 the difference lies in how it is injected: slowly for tissue imaging (MRI) and rapidly for vascular mapping (MRA).<\/div>\n<div><\/div>\n<div>8. Standard CMR Protocol<\/div>\n<div><\/div>\n<div>A full CMR study includes:<\/div>\n<div><span> \u2022 Cine imaging (2-, 3-, and 4-chamber + short-axis views).<\/span><\/div>\n<div><span> \u2022 Gadolinium contrast (0.1\u20130.2 mmol\/kg).<\/span><\/div>\n<div><span> \u2022 LGE imaging 10\u201315 minutes post-contrast for scar or fibrosis visualization.<\/span><\/div>\n<div>A rapid protocol may combine cine and LGE, with optional stress perfusion for ischemia detection.<\/div>\n<div><\/div>\n<div>9. Acute vs. Chronic MI on CMR<\/div>\n<div><span> \u2022 Acute MI: T2 detects edema; LGE shows acute injury.<\/span><\/div>\n<div><span> \u2022 Chronic MI: CMR measures scar depth \u2014 &lt; 50% wall thickness scarred suggests viable myocardium.<\/span><\/div>\n<div><span> \u2022 True aneurysm: wide neck; false aneurysm: narrow neck (contained rupture).<\/span><\/div>\n<div><\/div>\n<div>10. CT vs. CMR \u2014 Complementary Tools<\/div>\n<div><span> \u2022 CT (CCTA): best for coronary arteries \u2014 answers \u201cAre the arteries blocked?\u201d<\/span><\/div>\n<div><span> \u2022 CMR: best for myocardial tissue and function \u2014 answers \u201cHow healthy is the heart muscle?\u201d<\/span><\/div>\n<div>Used together, they offer a complete anatomy + function + tissue approach.<\/div>\n<div><\/div>\n<div>11. How to Write a CMR Request in Clinical Practice<\/div>\n<div><\/div>\n<div>When a physician writes only \u201cCMR\u201d or \u201cCardiac MRI\u201d, the radiologist interprets it as a standard comprehensive cardiac study including cine, LGE, and basic perfusion imaging.<\/div>\n<div><\/div>\n<div>However, the best practice is to specify the goal of the scan clearly, for example:<\/div>\n<div><span> \u2022 \u201cCMR \u2013 LV function and wall motion (cine imaging).\u201d<\/span><\/div>\n<div><span> \u2022 \u201cCMR \u2013 Stress\/rest perfusion to rule out ischemia.\u201d<\/span><\/div>\n<div><span> \u2022 \u201cCMR \u2013 LGE for viability and scar evaluation.\u201d<\/span><\/div>\n<div><span> \u2022 \u201cCMR \u2013 T2 mapping for acute injury or myocarditis.\u201d<\/span><\/div>\n<div><span> \u2022 \u201cCMRA \u2013 Evaluate aorta, pulmonary arteries, and proximal coronary arteries (though less precise than CT angiography)\u201d<\/span><\/div>\n<div><span> \u2022 \u201cCardiac MRI (CMR) including MR Angiography if clinically indicated.\u201d<\/span><\/div>\n<div><\/div>\n<div>12. Clinical Value<\/div>\n<div>CMR and CCTA together provide a complete understanding of ischemic heart disease \u2014 one defines arterial anatomy, the other evaluates myocardial health.<\/div>\n<div>This integrated approach improves diagnostic precision, guides therapy, and enhances long-term outcomes.<\/div>\n<div><\/div>\n<div><a href=\"https:\/\/www.medscape.org\/viewarticle\/mri-workup-ischemic-heart-disease-insights-and-innovations-2025a1000oj5\">https:\/\/www.medscape.org\/viewarticle\/mri-workup-ischemic-heart-disease-insights-and-innovations-2025a1000oj5<\/a><\/div>\n<div><\/div>\n<div><a href=\"https:\/\/jcmr-online.biomedcentral.com\/articles\/10.1186\/s12968-023-00950-z?\">https:\/\/jcmr-online.biomedcentral.com\/articles\/10.1186\/s12968-023-00950-z?<\/a><\/div>\n<div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>MRI Workup of Ischemic Heart Disease \u2014 Insights and Innovations Source: Medscape (Supported by Bayer) Date: 21, October 2025 Keynotes: 1. Purpose Cardiac Magnetic Resonance (CMR) is a specialized, non-invasive test used to assess heart muscle structure, function, perfusion, and scarring. It complements coronary CT angiography (CCTA), which focuses mainly on coronary artery visualization. 2. [&hellip;]<\/p>\n","protected":false},"author":145,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-9007","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/9007","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/145"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=9007"}],"version-history":[{"count":1,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/9007\/revisions"}],"predecessor-version":[{"id":9008,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/9007\/revisions\/9008"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=9007"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=9007"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=9007"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}